Načítá se...
Efficacy of Therapies After Galeterone in Patients With Castration-resistant Prostate Cancer
We evaluated the prostate-specific antigen (PSA) responses to subsequent therapy in patients previously treated with galeterone. Twenty-seven patients were included in the analysis. Modest PSA responses were seen in patients receiving first-line and second-line subsequent therapies. The response to...
Uloženo v:
| Vydáno v: | Clin Genitourin Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853188/ https://ncbi.nlm.nih.gov/pubmed/27890446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2016.10.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|